▁Sub 10.375
title 8.390625
: 4.7578125
▁Trade 10.53125
▁Rest 8.0546875
rict 5.24609375
ions 6.359375
▁and 4.046875
▁Market 7.1640625
▁Ch 7.94140625
alleng 4.6328125
es 1.0634765625
▁A 6.8671875
ffect 4.2734375
▁Le 8.625
ading 2.2265625
▁Medical 10.3125
▁Device 6.3203125
▁Man 6.0
ufact 0.93310546875
urer 2.115234375
' 4.8828125
s 0.10150146484375
▁Fin 7.42578125
an 0.76025390625
cial 0.0455322265625
▁Performance 7.65625
▁ 5.01953125
<0x0A> 11.859375
Introduction 7.15234375
: 2.65234375
<0x0A> 2.845703125
In 3.486328125
▁a 3.3984375
▁quarter 9.0546875
▁marked 7.8671875
▁by 0.095458984375
▁unexpected 7.51171875
▁hur 7.85546875
d 0.00785064697265625
les 0.007144927978515625
, 1.021484375
▁St 8.2265625
. 1.333984375
▁J 4.5
ude 0.01025390625
▁Medical 0.85595703125
▁Inc 2.62890625
., 2.58984375
▁a 1.11328125
▁leading 2.751953125
▁global 1.5517578125
▁medical 0.2958984375
▁device 0.444091796875
▁manufact 1.3818359375
urer 0.06781005859375
, 0.35400390625
▁reported 3.29296875
▁lower 6.36328125
- 0.87353515625
than 0.00638580322265625
- 0.0301055908203125
antic 2.90625
ip 0.0002067089080810547
ated 0.0007319450378417969
▁prof 3.794921875
its 0.0007719993591308594
▁due 4.1953125
▁to 0.0750732421875
▁a 1.6591796875
▁missed 7.41796875
▁heart 10.640625
▁val 3.5390625
ve 0.0027008056640625
▁sale 4.77734375
▁to 2.84375
▁Iran 10.4453125
▁and 1.638671875
▁a 1.412109375
▁combination 7.9453125
▁of 0.489013671875
▁other 2.42578125
▁factors 0.95263671875
. 0.318359375
▁Trade 9.765625
▁restrictions 3.26953125
▁and 1.5556640625
▁market 2.21484375
▁challeng 2.689453125
es 0.002544403076171875
▁have 2.380859375
▁played 4.875
▁a 0.18701171875
▁det 6.73828125
r 0.00229644775390625
iment 0.00015664100646972656
al 0.01155853271484375
▁role 0.1351318359375
▁in 0.336669921875
▁the 0.85400390625
▁company 0.955078125
' 0.0458984375
s 0.0009403228759765625
▁financial 2.009765625
▁performance 0.2310791015625
, 1.837890625
▁highlight 5.453125
ing 0.1092529296875
▁the 0.3486328125
▁complex 4.5078125
ities 0.499267578125
▁faced 3.955078125
▁by 0.1182861328125
▁business 3.498046875
es 0.2088623046875
▁in 1.2255859375
▁the 1.1787109375
▁medical 2.57421875
▁industry 2.037109375
. 0.329833984375
<0x0A> 1.064453125
Miss 7.890625
ed 0.185791015625
▁Sales 1.7724609375
▁O 3.935546875
pport 0.0079193115234375
unity 0.5908203125
▁in 2.19921875
▁Iran 0.92529296875
: 0.82568359375
<0x0A> 0.138427734375
St 1.2568359375
. 0.061614990234375
▁J 0.01849365234375
ude 0.0002834796905517578
▁Medical 0.243896484375
▁Inc 1.3681640625
. 0.38720703125
▁had 3.072265625
▁been 1.611328125
▁on 3.783203125
▁track 2.708984375
▁for 2.763671875
▁a 0.52099609375
▁strong 5.6875
▁third 4.01171875
▁quarter 0.13134765625
▁until 4.98046875
▁an 3.53515625
▁un 2.826171875
for 1.7490234375
ese 0.0059051513671875
en 0.01139068603515625
▁set 2.453125
back 0.061248779296875
▁occurred 2.53125
: 3.8359375
▁a 1.6611328125
▁missed 1.5234375
▁heart 2.3046875
▁val 0.01348114013671875
ve 0.0006976127624511719
▁sale 0.2548828125
▁to 0.143798828125
▁Iran 0.1607666015625
. 0.2388916015625
▁The 0.9150390625
▁potential 6.66015625
▁deal 1.7373046875
, 2.197265625
▁which 1.0537109375
▁could 2.869140625
▁have 0.0697021484375
▁significantly 4.9921875
▁boost 1.376953125
ed 0.00023305416107177734
▁the 0.63916015625
▁company 0.2191162109375
' 0.029571533203125
s 0.00020503997802734375
▁reven 2.6875
ues 0.00010788440704345703
, 0.4951171875
▁was 0.471923828125
▁th 4.3671875
wart 6.92605972290039e-05
ed 7.319450378417969e-05
▁by 0.88427734375
▁trade 5.1484375
▁restrictions 0.349365234375
▁im 2.017578125
posed 0.000141143798828125
▁on 1.970703125
▁Iran 0.93701171875
▁by 0.845703125
▁the 0.1318359375
▁United 0.69775390625
▁States 0.01532745361328125
, 2.41796875
▁leaving 3.837890625
▁St 1.0419921875
. 0.005619049072265625
▁J 0.011810302734375
ude 0.00019252300262451172
▁Medical 1.212890625
▁with 2.0703125
▁limited 4.1328125
▁options 0.4765625
▁for 1.7431640625
▁growth 4.1796875
▁in 1.3896484375
▁the 0.55810546875
▁region 1.7158203125
. 0.0863037109375
▁Despite 3.5546875
▁being 4.0390625
▁a 1.51171875
▁leading 2.8203125
▁player 1.7626953125
▁in 0.0380859375
▁the 0.1346435546875
▁card 3.40234375
iac 0.7236328125
▁medical 3.693359375
▁device 0.8310546875
▁sector 3.48046875
, 0.06768798828125
▁the 0.481689453125
▁firm 4.59765625
▁was 1.7958984375
▁unable 0.8193359375
▁to 0.0019931793212890625
▁capital 1.52734375
ize 0.0333251953125
▁on 0.01004791259765625
▁a 2.923828125
▁market 3.927734375
▁with 2.962890625
▁immense 3.982421875
▁potential 0.379638671875
▁due 1.53515625
▁to 0.00800323486328125
▁these 3.3515625
▁restrictions 2.87890625
. 0.2080078125
<0x0A> 0.318603515625
Tra 4.78125
de 0.005786895751953125
▁Rest 0.796875
rict 0.03216552734375
ions 0.087646484375
▁and 1.2373046875
▁Global 5.25390625
▁Dynam 9.46875
ics 0.0279998779296875
: 0.363037109375
<0x0A> 0.006259918212890625
Wh 4.13671875
ile 0.00928497314453125
▁St 1.986328125
. 0.006488800048828125
▁J 0.006465911865234375
ude 0.00018668174743652344
▁Medical 0.022430419921875
' 2.56640625
s 0.00025534629821777344
▁missed 6.0546875
▁sale 2.126953125
▁in 2.328125
▁Iran 0.04144287109375
▁height 9.6875
ened 0.72802734375
▁their 5.39453125
▁financial 2.419921875
▁challeng 1.9462890625
es 5.054473876953125e-05
, 0.14892578125
▁they 2.802734375
▁also 1.98046875
▁symbol 9.9609375
ize 0.7861328125
▁the 0.6591796875
▁bro 2.087890625
ader 7.510185241699219e-05
▁problems 5.171875
▁faced 1.169921875
▁by 0.0245819091796875
▁medical 2.408203125
▁supp 7.09375
liers 0.00714111328125
▁in 1.396484375
▁a 2.158203125
▁dynamic 4.81640625
▁global 0.3837890625
▁market 0.64599609375
. 0.45556640625
▁The 1.732421875
▁ge 6.37890625
opol 0.1236572265625
it 2.9802322387695312e-05
ical 0.053558349609375
▁landscape 1.95703125
, 3.275390625
▁san 10.8203125
ctions 0.0321044921875
, 0.560546875
▁and 0.490234375
▁trade 1.326171875
▁reg 3.931640625
ulations 0.055084228515625
▁continue 2.62109375
▁to 0.0031070709228515625
▁shape 3.419921875
▁the 0.424072265625
▁medical 2.36328125
▁device 1.30859375
▁industry 0.3740234375
, 0.66162109375
▁pos 4.66015625
ing 0.0016727447509765625
▁hur 6.05078125
d 3.695487976074219e-05
les 0.0008220672607421875
▁that 2.822265625
▁are 2.65234375
▁difficult 0.8935546875
▁for 1.828125
▁even 3.427734375
▁established 5.1015625
▁companies 0.94921875
▁to 0.1707763671875
▁overcome 0.384033203125
. 0.0258026123046875
▁The 2.716796875
▁market 4.23828125
▁dynamics 2.6484375
, 3.044921875
▁combined 3.9921875
▁with 0.0017080307006835938
▁string 6.3828125
ent 0.0007653236389160156
▁regul 2.02734375
atory 0.0006270408630371094
▁environments 5.10546875
, 0.56689453125
▁create 3.138671875
▁complex 3.615234375
▁obst 4.46875
acles 0.0008959770202636719
▁that 1.2568359375
▁can 1.130859375
▁h 2.798828125
inder 0.00554656982421875
▁growth 1.8388671875
▁opportun 3.505859375
ities 1.0013580322265625e-05
▁and 1.4931640625
▁impact 5.0
▁financial 2.900390625
▁results 2.505859375
▁for 3.130859375
▁companies 2.14453125
▁like 1.80078125
▁St 0.0086517333984375
. 0.00586700439453125
▁J 0.00806427001953125
ude 0.00018990039825439453
▁Medical 0.051513671875
. 0.31494140625
<0x0A> 0.10272216796875
Comp 4.7734375
et 0.249267578125
itive 0.72265625
▁Land 1.7314453125
s 0.0075531005859375
cape 7.152557373046875e-06
▁and 1.8330078125
▁Techn 6.7265625
ological 0.0733642578125
▁Ad 2.275390625
van 0.01020050048828125
c 0.29833984375
ements 0.00030231475830078125
: 0.02679443359375
<0x0A> 0.0027637481689453125
The 1.583984375
▁medical 0.6357421875
▁device 0.2232666015625
▁industry 0.251708984375
▁is 0.309814453125
▁highly 1.814453125
▁compet 0.0771484375
itive 4.565715789794922e-05
, 0.50390625
▁with 0.53076171875
▁constant 8.125
▁adv 3.017578125
anc 0.038818359375
ements 1.3470649719238281e-05
▁pushing 7.578125
▁companies 1.771484375
▁to 0.0653076171875
▁innov 1.79296875
ate 0.0008769035339355469
▁and 0.251708984375
▁stay 1.2763671875
▁ahead 0.313720703125
. 3.982421875
▁During 7.25
▁the 0.404296875
▁third 0.46337890625
▁quarter 0.005207061767578125
, 0.36328125
▁St 0.224853515625
. 0.0038127899169921875
▁J 0.004207611083984375
ude 7.617473602294922e-05
▁Medical 0.0126800537109375
▁faced 1.619140625
▁st 2.4921875
iff 0.0165557861328125
▁competition 0.040069580078125
▁from 0.19140625
▁rival 5.85546875
▁manufact 2.44921875
ur 0.0090789794921875
ers 3.933906555175781e-06
, 0.79248046875
▁many 4.53515625
▁of 0.008575439453125
▁whom 0.611328125
▁introduced 4.63671875
▁new 0.267822265625
▁products 0.51708984375
▁and 0.7744140625
▁techn 1.052734375
ologies 0.452880859375
. 2.416015625
▁These 2.021484375
▁innov 3.12890625
ations 0.03179931640625
▁not 4.34765625
▁only 0.00191497802734375
▁required 7.9296875
▁St 4.20703125
. 0.003696441650390625
▁J 0.0034027099609375
ude 0.00012302398681640625
▁Medical 0.0775146484375
▁to 0.0129852294921875
▁improve 4.52734375
▁their 0.5498046875
▁offer 2.70703125
ings 0.0006914138793945312
▁but 1.9921875
▁also 0.034027099609375
▁necess 3.34375
itated 0.0211334228515625
▁significant 1.9873046875
▁invest 0.5029296875
ments 0.1959228515625
▁in 0.294677734375
▁research 0.5087890625
▁and 0.01145172119140625
▁development 0.0028553009033203125
▁to 1.787109375
▁maintain 3.265625
▁a 1.341796875
▁compet 0.347900390625
itive 9.322166442871094e-05
▁edge 0.321533203125
. 0.11029052734375
▁However 6.28515625
, 0.0008683204650878906
▁bal 11.828125
ancing 0.056365966796875
▁the 2.1875
▁pressure 6.203125
▁to 1.9404296875
▁innov 0.462158203125
ate 0.00023603439331054688
▁and 2.470703125
▁remain 2.69140625
▁cost 3.896484375
- 0.32080078125
comp 3.5390625
et 7.593631744384766e-05
itive 0.00019240379333496094
▁proved 1.71484375
▁challeng 0.9697265625
ing 7.021427154541016e-05
▁for 0.53173828125
▁the 0.1990966796875
▁company 0.5732421875
, 0.62890625
▁further 4.4609375
▁impact 3.076171875
ing 0.003082275390625
▁their 0.31103515625
▁prof 3.54296875
its 0.001361846923828125
. 0.361083984375
<0x0A> 0.042388916015625
CO 7.3203125
VID 0.0877685546875
- 0.07720947265625
1 0.009674072265625
9 0.0003032684326171875
▁Pan 3.09375
demic 0.000720977783203125
▁and 1.216796875
▁Hospital 7.4375
▁Bud 9.09375
get 1.5029296875
▁Con 6.24609375
stra 0.005657196044921875
ints 0.0259552001953125
: 0.039306640625
<0x0A> 0.00243377685546875
An 4.25
other 0.3193359375
▁factor 1.427734375
▁contrib 1.7490234375
uting 4.601478576660156e-05
▁to 0.00234222412109375
▁St 0.27294921875
. 0.003551483154296875
▁J 0.00403594970703125
ude 0.0001571178436279297
▁Medical 0.011871337890625
' 0.04278564453125
s 0.0005335807800292969
▁third 2.66015625
- 0.5634765625
qu 0.0005369186401367188
arter 5.924701690673828e-05
▁strugg 2.072265625
les 3.409385681152344e-05
▁was 0.1607666015625
▁the 0.239501953125
▁on 2.552734375
going 0.120849609375
▁COVID 0.463134765625
- 0.003509521484375
1 0.0006461143493652344
9 1.0251998901367188e-05
▁pan 0.0098419189453125
demic 3.349781036376953e-05
. 0.70458984375
▁H 6.7578125
osp 0.0022125244140625
it 3.5762786865234375e-05
als 3.993511199951172e-05
▁glob 5.85546875
ally 5.3048133850097656e-05
▁faced 2.25
▁significant 2.009765625
▁financial 2.326171875
▁press 2.04296875
ures 4.935264587402344e-05
▁due 0.72998046875
▁to 0.0008440017700195312
▁increased 3.453125
▁health 3.373046875
care 0.1439208984375
▁exp 2.58984375
end 0.6552734375
iture 3.423828125
▁and 0.8056640625
▁reduced 2.16796875
▁patient 1.7119140625
▁volumes 0.80859375
. 0.5849609375
▁This 1.12109375
, 2.916015625
▁in 0.8193359375
▁turn 0.0253448486328125
, 0.00022327899932861328
▁led 1.380859375
▁to 0.04351806640625
▁budget 2.76171875
▁constraints 0.30859375
▁and 1.0048828125
▁delayed 5.17578125
▁or 3.244140625
▁can 0.5234375
ce 0.0046234130859375
led 1.9073486328125e-06
▁medical 2.0703125
▁device 0.8623046875
▁purch 0.418701171875
ases 0.009857177734375
, 1.0712890625
▁affect 4.54296875
ing 4.1365623474121094e-05
▁St 0.71923828125
. 0.00177764892578125
▁J 0.00257110595703125
ude 6.914138793945312e-05
▁Medical 0.07476806640625
' 0.146240234375
s 0.0005178451538085938
▁profit 3.5078125
ability 0.056640625
. 0.23388671875
▁The 2.15625
▁uncertainty 5.93359375
▁surrounding 0.80712890625
▁the 0.28271484375
▁pan 0.57421875
demic 7.62939453125e-05
▁and 1.5107421875
▁its 0.74462890625
▁impact 1.01171875
▁on 0.061737060546875
▁the 0.73779296875
▁health 1.5029296875
care 0.0167388916015625
▁industry 0.8671875
▁remains 3.05078125
▁a 1.4267578125
▁key 1.9892578125
▁challenge 1.8466796875
▁for 0.30908203125
▁medical 1.7861328125
▁device 0.82763671875
▁manufact 0.315673828125
ur 0.01221466064453125
ers 3.6954879760742188e-06
. 1.31640625
<0x0A> 0.1055908203125
Con 3.33984375
clusion 0.1949462890625
: 0.1932373046875
<0x0A> 0.10028076171875
St 1.5859375
. 0.01702880859375
▁J 0.00473785400390625
ude 5.829334259033203e-05
▁Medical 0.00580596923828125
▁Inc 1.1630859375
. 0.61279296875
▁faced 1.1494140625
▁notable 7.61328125
▁challeng 0.440673828125
es 3.3020973205566406e-05
▁that 5.67578125
▁impact 1.1845703125
ed 0.003490447998046875
▁their 0.286376953125
▁third 2.111328125
- 0.15966796875
qu 0.0003921985626220703
arter 0.00017273426055908203
▁prof 1.47265625
its 5.710124969482422e-05
, 1.5322265625
▁including 1.298828125
▁a 1.890625
▁missed 0.0704345703125
▁heart 0.9150390625
▁val 0.006732940673828125
ve 0.00023055076599121094
▁sale 0.11358642578125
▁to 0.1781005859375
▁Iran 0.0135650634765625
▁due 3.482421875
▁to 0.00069427490234375
▁trade 0.7978515625
▁restrictions 0.049957275390625
, 0.78369140625
▁increasing 5.2890625
▁competition 0.92041015625
, 0.8798828125
▁the 4.78515625
▁COVID 0.76220703125
- 0.0029296875
1 0.0003421306610107422
9 4.1604042053222656e-05
▁pan 0.00243377685546875
demic 3.707408905029297e-05
, 0.1505126953125
▁and 0.03826904296875
▁hosp 8.2734375
it 0.0012683868408203125
als 0.006206512451171875
' 1.2138671875
▁budget 0.4404296875
▁constraints 0.053466796875
. 0.0506591796875
▁As 3.4453125
▁the 1.552734375
▁world 3.35546875
▁trans 5.4296875
itions 0.0023040771484375
▁into 2.267578125
▁a 0.428466796875
▁post 0.44921875
- 0.0082550048828125
pan 0.62939453125
demic 5.447864532470703e-05
▁era 1.4306640625
, 0.06646728515625
▁it 1.8515625
▁is 0.98193359375
▁cru 1.8818359375
cial 0.0005869865417480469
▁for 0.3388671875
▁medical 0.90478515625
▁device 0.29248046875
▁manufact 0.257080078125
ur 0.007259368896484375
ers 9.5367431640625e-07
▁and 5.640625
▁polic 7.1015625
ym 1.7881393432617188e-06
akers 7.510185241699219e-05
▁to 0.118896484375
▁navigate 5.31640625
▁these 0.5380859375
▁challeng 0.79736328125
es 0.005496978759765625
▁collabor 6.51171875
atively 0.0006470680236816406
. 1.830078125
▁St 2.97265625
rik 7.55078125
ing 0.001220703125
▁a 0.921875
▁balance 0.09051513671875
▁between 0.01145172119140625
▁ens 5.12890625
uring 0.00043892860412597656
▁patient 1.2177734375
▁safety 0.82568359375
, 3.615234375
▁prom 3.001953125
oting 0.0037555694580078125
▁innov 0.4951171875
ation 0.0261688232421875
, 0.0625
▁and 0.0254974365234375
▁maintain 1.2783203125
ing 5.6743621826171875e-05
▁a 2.234375
▁compet 0.303955078125
itive 0.0004589557647705078
▁market 3.99609375
▁will 2.240234375
▁be 0.54052734375
▁essential 1.6689453125
▁for 0.880859375
▁sust 3.455078125
ained 1.685546875
▁growth 0.67724609375
▁in 1.103515625
▁the 0.1143798828125
▁medical 2.111328125
▁industry 0.626953125
. 0.08758544921875
